MFDS — authorised 18 March 2016
- Marketing authorisation holder: ELUSYS THERAPEUTICS INC
- Status: likely_approved
🇰🇷 Anthim in South Korea
MFDS authorised Anthim on 18 March 2016
Marketing authorisation
Anthim in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Other approved in South Korea
Frequently asked questions
Is Anthim approved in South Korea?
Yes. MFDS authorised it on 18 March 2016.
Who is the marketing authorisation holder for Anthim in South Korea?
ELUSYS THERAPEUTICS INC holds the South Korean marketing authorisation.